Nuo Therapeutics, Inc. Total Revenue

• Nuo Therapeutics, Inc. showed a decrease of -93.7% in Total Revenue from 2015 to 2017.
• This data is from Nuo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on April 16, 2018.
• XBRL data for this metric is available from 2010 to 2017 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $1.15 million | Q3 2010: $1.30 million | Q1 2011: $1.37 million | Q2 2011: $1.39 million | Q3 2011: $1.53 million | Q1 2012: $3.02 million | Q2 2012: $3.69 million | Q3 2012: $1.76 million | Q1 2013: $2.32 million | Q2 2013: $2.42 million | Q3 2013: $3.37 million | Q1 2014: $1.85 million | Q2 2014: $2.33 million | Q3 2014: $1.69 million | Q1 2015: $4.84 million | Q2 2015: $2.90 million | Q3 2015: $2.17 million | Q1 2016: $1.41 million | Q2 2016: $134.9 thousand | Q3 2016: $176.8 thousand | Q1 2017: $172.7 thousand | Q2 2017: $188.6 thousand | Q3 2017: $162.2 thousand.
• Over the full 7 years of available data (2010 to 2017), Nuo Therapeutics, Inc.'s Total Revenue has declined by 81.6%.
• Historical annual values: Fiscal year 2017: $721.0 thousand | Fiscal year 2015: $11.51 million | Fiscal year 2014: $7.76 million | Fiscal year 2013: $11.57 million | Fiscal year 2012: $10.56 million | Fiscal year 2011: $7.25 million | Fiscal year 2010: $3.91 million.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026